Cilta-cel demonstrates superior efficacy and durability in treating high-risk myeloma, balancing effectiveness with safety concerns for patients.

India has significantly increased its MBBS and postgraduate medical seats, aiming to boost healthcare accessibility and quality. While capacity has expanded considerably, particularly in states like ...

As competition for MBBS seats intensifies, demand for global medical education is set to grow further. With limited seats in government colleges and rising costs in private institutions, a growing ...

Why didn’t you do a direct comparison between patients undergoing TP prostate biopsy and patients undergoing TRUS biopsy? Dr. Grummet: That was beyond the scope of our resources at the time, and our ...

A recent trial reveals cemiplimab significantly reduces recurrence in high-risk cutaneous squamous cell carcinoma, setting a ...